Dr. Lagamma is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
95 Grasslands Rd
Valhalla, NY 10595Phone+1 914-493-8558Fax+1 914-493-1488
Summary
- Dr. Edmund F. La Gamma is Professor of Pediatrics, Biochemistry & Molecular Biology at the New York Medical College. He is the Chief of the Division of Newborn Medicine and is the Director of the 49-bed Regional Neonatal Center of the Maria Fareri Children’s Hospital. His Division has the 3rd largest fellowship program in America with a 98% board pass rate since 1999. Dr. La Gamma was an elected member of the Council of the Society for Pediatric Research; is the past President of the New York Perinatal Society; a former Secretary of the Easter SPR as well as elected their “Mentor of the Year 2015” and is the recipient of grants from the NIH, NSF, March of Dimes, Dysautonomia Foundation, American Heart Association and industry. He has been on various regional and national “Best Doctors” lists for over 15 years. He has served on multiple NIH Study Sections. Dr. La Gamma has published over 125 peer reviewed reports and 25 invited chapters. He holds two patents on clinically relevant research and is a consultant to industry.
Education & Training
- Cold Spring Harborno degree, Molecular Neuroscience, 1982
- City College of the City University of New York (CCNY)BS, Physical Chemistry, Baskerville Chemical Society, 1973
- University of California San Francisco School of MedicinePost-Doctoral Fellowship, 1980 - 1981
- New York Presbyterian Hospital (Cornell Campus)Fellowship, Neonatal-Perinatal Medicine, 1978 - 1979
- New York Presbyterian Hospital (Cornell Campus)Residency, Pediatrics, 1976 - 1978
- New York Medical CollegeClass of 1976
Certifications & Licensure
- NY State Medical License 1977 - 2026
- American Board of Pediatrics Pediatrics
- American Board of Pediatrics Neonatal-Perinatal Medicine
Awards, Honors, & Recognition
- Mentor of the Year award, Eastern Society for Perinatal Research, 2015
- Stanly James Award NYS Perinatal Association, 2010
- 31st Annual Gala Honoree Westchester Medical Center’s, 2010
- Join now to see all
Clinical Trials
- Preterm Erythropoietin Neuroprotection Trial (PENUT Trial) Start of enrollment: 2013 Dec 01
- Study of Thyroid Hormones in Prematures Start of enrollment: 2020 Jul 01
- Prevention of Transfusion Related Acute Gut Injury (TRAGI) in Extremely Low Gestational Age Neonates (ELGANs) Using iNO Start of enrollment: 2019 Feb 06
Publications & Presentations
PubMed
- 2 citationsImpact of the COVID-19 pandemic on the incidence of prematurity: critical role of gestational age and environment.Barry Weinberger, Jasmin Divers, Deborah Campbell, Steven Ham, Courtney Juliano
American Journal of Obstetrics and Gynecology. 2022-06-01 - 4 citationsGestational age, sex, and time affect urine biomarker concentrations in extremely low gestational age neonates.David J. Askenazi, Brian Halloran, Patrick J. Heagerty, Robert H. Schmicker, Patrick D. Brophy
Pediatric Research. 2021-11-30 - 6 citationsAssociation between Term Equivalent Brain Magnetic Resonance Imaging and 2-Year Outcomes in Extremely Preterm Infants: A Report from the Preterm Erythropoietin Neuropr...Dennis E. Mayock, Semsa Gogcu, Mihai Puia-Dumitrescu, Dennis W. W. Shaw, Jason N. Wright
The Journal of Pediatrics. 2021-08-26
Journal Articles
- Effect of High-Dose Erythropoietin on Blood Transfusions in Extremely Low Gestational Age NeonatesSandra E Juul, Dennis E Mayock, Kaashif A Ahmad, Ellen Bendel-Stenzel, Mariana Baserga, Edmund F Lagamma, Nancy Fahim, Andrea Lampland, Ivan D Frantz, Janine Khan, Mau..., JAMA Pediatrics
Authored Content
- Effect of High-Dose Erythropoietin on Blood Transfusions in Extremely Low Gestational Age NeonatesAugust 2020
- Effect of High-Dose Erythropoietin on Blood Transfusions in Extremely Low Gestational Age NeonatesAugust 2020
Grant Support
- Phase I Study Of Thyroid Hormone In PrematuresNational Institute Of Neurological Disorders And Stroke2003–2007
- Enkephalin Gene Regulatory ProteinsNational Science Foundation1988–1991
- Stress Mediated Regulation of Adrenal Neurotransmitters,American Heart Association1985
- Ontogeny Of Fetal Autonomic Cardiovascular RegulationNational Heart, Lung, And Blood Institute1985
Research History
- Professor of Pediatrics, Biochemistry & Molecular BiologyAstrocytes For Gene Therapy: Inventors: E.F. LaGamma, G. Weisinger, R.E. Strecker, N.J. Lenn, Granted 2000 – U.S. #08/862,438 patent #6,106,827 GCSF Therapy for Neonatal Sepsis & neutropenia, Granted 2000 #08/851,044 Patent #6,162,426. Inventor: E.F.LaGamma2000 - Present
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: